Your browser doesn't support javascript.
loading
Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline.
Teipel, Stefan J; Dyrba, Martin; Kleineidam, Luca; Brosseron, Frederic; Levin, Fedor; Bruno, Davide; Buerger, Katharina; Cosma, Nicoleta; Schneider, Luisa-Sophie; Düzel, Emrah; Glanz, Wenzel; Fliessbach, Klaus; Janowitz, Daniel; Kilimann, Ingo; Laske, Christoph; Munk, Matthias H; Maier, Franziska; Peters, Oliver; Pomara, Nunzio; Perneczky, Robert; Rauchmann, Boris-Stephan; Priller, Josef; Ramirez, Alfredo; Roy, Nina; Schneider, Anja; Spottke, Annika; Spruth, Eike J; Roeske, Sandra; Wagner, Michael; Wiltfang, Jens; Wolfsgruber, Steffen; Bartels, Claudia; Jessen, Frank; Heneka, Michael T.
Afiliación
  • Teipel SJ; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock Germany.
  • Dyrba M; Department of Psychosomatic Medicine University of Rostock Rostock Germany.
  • Kleineidam L; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock Germany.
  • Brosseron F; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn Germany.
  • Levin F; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry University of Bonn Medical Center Bonn Germany.
  • Bruno D; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn Germany.
  • Buerger K; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry University of Bonn Medical Center Bonn Germany.
  • Cosma N; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock Germany.
  • Schneider LS; School of Psychology Liverpool John Moores University Liverpool UK.
  • Düzel E; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Munich Germany.
  • Glanz W; Institute for Stroke and Dementia Research (ISD) University Hospital LMU Munich Munich Germany.
  • Fliessbach K; Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
  • Janowitz D; Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
  • Kilimann I; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Magdeburg Germany.
  • Laske C; Institute of Cognitive Neurology and Dementia Research (IKND) Otto-von-Guericke University Magdeburg Germany.
  • Munk MH; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Magdeburg Germany.
  • Maier F; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn Germany.
  • Peters O; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry University of Bonn Medical Center Bonn Germany.
  • Pomara N; Institute for Stroke and Dementia Research (ISD) University Hospital LMU Munich Munich Germany.
  • Perneczky R; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock Germany.
  • Rauchmann BS; Department of Psychosomatic Medicine University of Rostock Rostock Germany.
  • Priller J; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Tübingen Germany.
  • Ramirez A; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy University of Tübingen Tübingen Germany.
  • Roy N; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Tübingen Germany.
  • Schneider A; Department of Psychiatry and Psychotherapy University of Tübingen Tübingen Germany.
  • Spottke A; Department of Psychiatry University of Cologne Cologne Germany.
  • Spruth EJ; Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany.
  • Roeske S; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Berlin Germany.
  • Wagner M; Nathan Kline Institute for Psychiatric Research Orangeburg New York USA.
  • Wiltfang J; Department of Psychiatry School of Medicine New York University New York New York USA.
  • Wolfsgruber S; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Munich Germany.
  • Bartels C; Department of Psychiatry and Psychotherapy University Hospital LMU Munich Munich Germany.
  • Jessen F; Munich Cluster for Systems Neurology (SyNergy) Munich Munich Germany.
  • Heneka MT; Ageing Epidemiology Research Unit (AGE), School of Public Health Imperial College London London UK.
Alzheimers Dement (Amst) ; 16(1): e12510, 2024.
Article en En | MEDLINE | ID: mdl-38213951
ABSTRACT

INTRODUCTION:

We investigated the association of inflammatory mechanisms with markers of Alzheimer's disease (AD) pathology and rates of cognitive decline in the AD spectrum.

METHODS:

We studied 296 cases from the Deutsches Zentrum für Neurodegenerative Erkrankungen Longitudinal Cognitive Impairment and Dementia Study (DELCODE) cohort, and an extension cohort of 276 cases of the Alzheimer's Disease Neuroimaging Initiative study. Using Bayesian confirmatory factor analysis, we constructed latent factors for synaptic integrity, microglia, cerebrovascular endothelial function, cytokine/chemokine, and complement components of the inflammatory response using a set of inflammatory markers in cerebrospinal fluid.

RESULTS:

We found strong evidence for an association of synaptic integrity, microglia response, and cerebrovascular endothelial function with a latent factor of AD pathology and with rates of cognitive decline. We found evidence against an association of complement and cytokine/chemokine factors with AD pathology and rates of cognitive decline.

DISCUSSION:

Latent factors provided access to directly unobservable components of the neuroinflammatory response and their association with AD pathology and cognitive decline.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2024 Tipo del documento: Article